Mark Scioli, MD
Orthopedic Surgery · Lubbock, TXNPI 1619971249
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.9%), royalties or licence payments and travel and lodging — rather than concentrated in one kind of arrangement. Globus Medical accounts for 68.6% of it on its own, with 32 other manufacturers making up the rest. Among orthopedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $304.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$48K
- 4web, Inc.$10K
- Johnson & Johnson$4K
- Spineology Inc.$3K
- Rattan And Associates$1K
- Stryker$613
- plus $3K from 27 others
Across 7 payments — averaging $99,111 each. An ownership or investment interest held by the physician or an immediate family member.
- 4web, Inc.$694K
What the payments were for
- Royalty or licence$25,54136%
- Consulting fees$27,99540%
- Speaking & faculty fees$1,9503%
- Travel & lodging$8,36612%
- Food & beverage$5,0277%
- Education$1,2002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 97 | $48,103 |
| 4web, Inc. | 23 | $10,404 |
| Johnson & Johnson(3 entities) | 3 | $4,127 |
| Spineology Inc. | 4 | $2,831 |
| Rattan And Associates | 3 | $1,325 |
| Stryker | 13 | $613 |
| Integra Lifesciences Corporation | 6 | $434 |
| Si-bone, Inc. | 8 | $410 |
| Zimmer Biomet | 6 | $296 |
| Vertex | 6 | $140 |
| Spineart USA Inc | 3 | $133 |
| Pacira Therapeutics, Inc. | 9 | $125 |
| ETS Wound Care LLC | 1 | $104 |
| Baudax Bio Inc. | 6 | $103 |
| Orthalign Inc | 1 | $101 |
| Collegium Pharmaceutical, Inc. | 5 | $88 |
| Amgen | 5 | $86 |
| Ferring Pharmaceuticals Inc. | 5 | $80 |
| Nevro Corp. | 1 | $77 |
| Bioventus LLC | 4 | $70 |
| Axogen | 1 | $62 |
| Pacira Pharmaceuticals Incorporated | 3 | $56 |
| Choice Spine, LLC | 1 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $52 |
| Medtronic | 3 | $46 |
| Innovation Technologies Inc | 2 | $44 |
| Merck | 2 | $24 |
| Smith+Nephew | 1 | $22 |
| Mimedx Group, Inc. | 1 | $19 |
| Lifenet Health | 1 | $19 |
| Biocomposites Inc | 1 | $17 |
| Orthofix Medical, Inc. | 1 | $13 |
| Heron Therapeutics, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AERIAL$14,002
- SP-FIX$9,681
- OSTEOTOMY TRUSS SYSTEM$8,298
- SI-LOK$8,073
- Endoscopic Disc Instr.$5,525
- STRATAFIX$4,095
- RISE$3,155
- Elite Expandable Interbody System$2,500
- Excelsius - GPS$2,077
- RISE Intra LIF$1,771
- SPINE TRUSS SYSTEM$1,500
- Spine$1,235
- RISE-L . RISE-L A/L$801
- RISE-L$544
- CADENCE ANKLE REPLACEMENT SYSTEM$331
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$331
- Sable$325
- Fortress Pedicle Screw System$280
- iFuse Implant$141
- CREO$140
How this compares
$70,080 in reported general payments places this provider in the 90th percentile of 33 orthopedic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,535 | $40,651 |
| Xtampza ErOxycodone Myristate | 11 | $25,816 |
| Fentanyl | 131 | $15,615 |
| LyricaPregabalin | 13 | $11,195 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 115 | $3,214 |
| Pregabalin | 132 | $2,070 |
| Tizanidine Hcl | 158 | $1,886 |
| Morphine Sulfate ErMorphine Sulfate | 49 | $1,825 |
| Methocarbamol | 235 | $1,783 |
| Hydromorphone Hcl | 100 | $1,685 |
| Oxycodone Hcl | 73 | $1,448 |
| Tramadol Hcl | 153 | $1,333 |
| Gabapentin | 102 | $1,219 |
| Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen | 35 | $1,174 |
| Meloxicam | 367 | $1,053 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $88 | $25,81611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 33 orthopedic surgery providers in Texas.
Other orthopedic surgery in Lubbock
- Jason RamseyLubbock$13K
- Kenneth StephensonLubbock$3K
- Tony SmithermanLubbock$1K
- Patrick MolliganLubbock$0
- Steven BrotzmanAustin$336K
- Rajesh ArakalPlano$79K
- John SimsAmarillo$35K
- Katherine LiHouston$19K
- Michael MarkowitzPlano$13K
- Mark GreenbergIrving$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.